Correction: Al Subait et al. Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds. Int. J. Mol. Sci. 2025, 26, 736
Arwa Al Subait, Raghad H. Alghamdi, Rizwan Ali, Amani Alsharidah, Sarah Huwaizi, Reem A. Alkhodier, Aljawharah Saud Almogren, Barrak A. Alzomia, Ahmed Alaskar, Mohamed Boudjelal
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer, Lipids, and Metabolism · Peroxisome Proliferator-Activated Receptors
In the published publication [1], there was an error regarding the affiliation for Reem A. Alkhodier. In addition to affiliation 5, the updated affiliation should include: King Abdullah International Medical Research Center (KAIMRC), Ministry of National Guard Health Affairs (MNGHA), Riyadh 11481, Saudi Arabia.
Ahmed Alaskar was misspelled in the original publication. The corrected spelling appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Al Subait A. Alghamdi R.H. Ali R. Alsharidah A. Huwaizi S. Alkhodier R.A. Almogren A.S. Alzomia B.A. Alaskar A. Boudjelal M. Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds Int. J. Mol. Sci.20252673610.3390/ijms 2602073639859448 PMC 11766124 · doi ↗ · pubmed ↗